Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

For three weeks last May, employees of the AI giant Nvidia and Recursion Pharmaceuticals slept on the floor of a data center in Salt Lake City. They were there to build a machine that Recursion, a decade-old biotech company, believes will give it an edge in the contest to develop the next great new medicines: BioHive-2, the largest and fastest supercomputer ever to be used in the biopharmaceutical industry. It's an audacious bet that the future of America’s pharmaceutical industry will be as much...